Ignacio Inglessis-Azuaje, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Foramen Ovale, Patent | 11 | 2021 | 208 | 1.160 |
Why?
|
| Aortic Diseases | 2 | 2016 | 735 | 0.570 |
Why?
|
| Vascular Fistula | 1 | 2016 | 50 | 0.530 |
Why?
|
| Chagas Cardiomyopathy | 3 | 2004 | 71 | 0.510 |
Why?
|
| Catheterization | 10 | 2011 | 1428 | 0.490 |
Why?
|
| Heart Valve Diseases | 3 | 2016 | 1027 | 0.410 |
Why?
|
| Mitral Valve Stenosis | 6 | 2013 | 341 | 0.410 |
Why?
|
| Mitral Valve Insufficiency | 5 | 2023 | 1400 | 0.400 |
Why?
|
| Heart Valve Prosthesis Implantation | 5 | 2023 | 1553 | 0.390 |
Why?
|
| Coronary Stenosis | 4 | 2015 | 794 | 0.360 |
Why?
|
| Embolism, Paradoxical | 3 | 2021 | 54 | 0.330 |
Why?
|
| Heart Diseases | 2 | 2016 | 2781 | 0.330 |
Why?
|
| Aortic Valve | 3 | 2016 | 1955 | 0.330 |
Why?
|
| Thrombophilia | 3 | 2021 | 305 | 0.320 |
Why?
|
| Septal Occluder Device | 4 | 2020 | 125 | 0.270 |
Why?
|
| Angioplasty, Balloon, Coronary | 4 | 2009 | 1725 | 0.270 |
Why?
|
| Valsalva Maneuver | 1 | 2004 | 99 | 0.220 |
Why?
|
| Stroke | 9 | 2021 | 9757 | 0.220 |
Why?
|
| Heart Defects, Congenital | 3 | 2009 | 4671 | 0.200 |
Why?
|
| Hypertension, Pulmonary | 2 | 2013 | 1578 | 0.200 |
Why?
|
| Vasodilator Agents | 2 | 2006 | 973 | 0.180 |
Why?
|
| Hemodynamics | 7 | 2016 | 4159 | 0.180 |
Why?
|
| Nitroimidazoles | 2 | 1998 | 117 | 0.180 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 353 | 0.170 |
Why?
|
| Transposition of Great Vessels | 1 | 2023 | 581 | 0.160 |
Why?
|
| Stents | 4 | 2023 | 3179 | 0.160 |
Why?
|
| Aortic Valve Stenosis | 4 | 2016 | 2001 | 0.160 |
Why?
|
| Shock, Cardiogenic | 1 | 2004 | 709 | 0.160 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2004 | 628 | 0.160 |
Why?
|
| Device Removal | 1 | 2023 | 630 | 0.160 |
Why?
|
| Embolism | 2 | 2020 | 399 | 0.150 |
Why?
|
| Pacemaker, Artificial | 1 | 2023 | 807 | 0.150 |
Why?
|
| Mitral Valve | 4 | 2023 | 1465 | 0.150 |
Why?
|
| Ischemic Attack, Transient | 4 | 2020 | 882 | 0.140 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2016 | 352 | 0.140 |
Why?
|
| Image Enhancement | 1 | 2007 | 2885 | 0.140 |
Why?
|
| Treatment Outcome | 24 | 2023 | 64680 | 0.140 |
Why?
|
| Endocardium | 1 | 2017 | 248 | 0.140 |
Why?
|
| Atherectomy, Coronary | 2 | 2009 | 137 | 0.130 |
Why?
|
| Nitric Oxide | 1 | 2004 | 2135 | 0.130 |
Why?
|
| Aortography | 1 | 2016 | 421 | 0.120 |
Why?
|
| Angioplasty, Balloon | 2 | 2009 | 589 | 0.120 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2016 | 1086 | 0.110 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2017 | 477 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 3530 | 0.110 |
Why?
|
| Heart Transplantation | 3 | 2017 | 3233 | 0.110 |
Why?
|
| Coronary Angiography | 6 | 2015 | 4471 | 0.110 |
Why?
|
| Heart Rate | 2 | 2006 | 4195 | 0.110 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2015 | 307 | 0.100 |
Why?
|
| Aneurysm | 1 | 2015 | 337 | 0.100 |
Why?
|
| Drug-Eluting Stents | 2 | 2016 | 681 | 0.100 |
Why?
|
| Echocardiography | 7 | 2023 | 4989 | 0.100 |
Why?
|
| Middle Aged | 33 | 2021 | 220895 | 0.090 |
Why?
|
| Coronary Circulation | 2 | 2015 | 1569 | 0.090 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2016 | 607 | 0.090 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2004 | 451 | 0.090 |
Why?
|
| Vascular Resistance | 1 | 2013 | 930 | 0.090 |
Why?
|
| Balloon Occlusion | 1 | 2010 | 125 | 0.080 |
Why?
|
| Humans | 53 | 2023 | 761504 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2015 | 1096 | 0.080 |
Why?
|
| Male | 37 | 2023 | 360804 | 0.080 |
Why?
|
| Heart-Lung Transplantation | 1 | 2009 | 87 | 0.080 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2009 | 64 | 0.080 |
Why?
|
| Tissue Donors | 1 | 2017 | 2331 | 0.070 |
Why?
|
| Myocardium | 2 | 2017 | 4726 | 0.070 |
Why?
|
| Coronary Artery Disease | 3 | 2016 | 6403 | 0.070 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2009 | 217 | 0.070 |
Why?
|
| Female | 37 | 2023 | 392644 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2009 | 3627 | 0.070 |
Why?
|
| Rheumatic Heart Disease | 1 | 2008 | 163 | 0.070 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 1927 | 0.070 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 1489 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 1188 | 0.070 |
Why?
|
| Follow-Up Studies | 11 | 2016 | 39106 | 0.070 |
Why?
|
| Coronary Artery Bypass | 2 | 2006 | 2188 | 0.070 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2007 | 164 | 0.070 |
Why?
|
| Diltiazem | 1 | 2006 | 131 | 0.070 |
Why?
|
| Coronary Vasospasm | 1 | 2006 | 81 | 0.070 |
Why?
|
| Heart Septal Defects | 1 | 2007 | 190 | 0.060 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2010 | 866 | 0.060 |
Why?
|
| Recurrence | 4 | 2020 | 8465 | 0.060 |
Why?
|
| Collateral Circulation | 1 | 2007 | 294 | 0.060 |
Why?
|
| Prospective Studies | 9 | 2023 | 54425 | 0.060 |
Why?
|
| Adult | 20 | 2023 | 221177 | 0.060 |
Why?
|
| Biopsy | 1 | 2017 | 6766 | 0.060 |
Why?
|
| Nitroglycerin | 1 | 2006 | 329 | 0.060 |
Why?
|
| Lipoma | 1 | 2007 | 293 | 0.060 |
Why?
|
| Aortic Coarctation | 1 | 2007 | 275 | 0.060 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2004 | 38 | 0.060 |
Why?
|
| Electrocardiography | 4 | 2006 | 6377 | 0.060 |
Why?
|
| Waiting Lists | 1 | 2009 | 765 | 0.060 |
Why?
|
| Femoral Artery | 1 | 2008 | 826 | 0.060 |
Why?
|
| Hospital Mortality | 6 | 2017 | 5294 | 0.060 |
Why?
|
| Sick Sinus Syndrome | 1 | 2023 | 44 | 0.060 |
Why?
|
| Suture Techniques | 1 | 2008 | 769 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 20570 | 0.060 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2008 | 576 | 0.060 |
Why?
|
| Heart Neoplasms | 1 | 2007 | 362 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 11460 | 0.050 |
Why?
|
| Parasympathetic Nervous System | 1 | 2004 | 142 | 0.050 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2023 | 56 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2009 | 1302 | 0.050 |
Why?
|
| Prostheses and Implants | 2 | 2007 | 1271 | 0.050 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 592 | 0.050 |
Why?
|
| Acute Disease | 3 | 2004 | 7237 | 0.050 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2010 | 992 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2012 | 2751 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2947 | 0.050 |
Why?
|
| Aged | 19 | 2023 | 169289 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 2 | 2006 | 1496 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2004 | 1157 | 0.050 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2017 | 223 | 0.050 |
Why?
|
| Chi-Square Distribution | 3 | 2013 | 3416 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2003 | 577 | 0.050 |
Why?
|
| Aged, 80 and over | 9 | 2017 | 58976 | 0.050 |
Why?
|
| Tricuspid Valve | 1 | 2023 | 410 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2023 | 15842 | 0.040 |
Why?
|
| Risk Assessment | 7 | 2011 | 23995 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2009 | 1161 | 0.040 |
Why?
|
| Coronary Restenosis | 1 | 2003 | 396 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 1222 | 0.040 |
Why?
|
| Tyrosine | 1 | 2003 | 1440 | 0.040 |
Why?
|
| Trypanosomiasis | 1 | 1998 | 8 | 0.040 |
Why?
|
| Proteomics | 1 | 2012 | 3849 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2011 | 1852 | 0.040 |
Why?
|
| Tuberous Sclerosis | 1 | 2007 | 1030 | 0.040 |
Why?
|
| Heparin | 1 | 2006 | 1634 | 0.040 |
Why?
|
| Equipment Design | 1 | 2007 | 3510 | 0.040 |
Why?
|
| Microcirculation | 1 | 2003 | 1273 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2009 | 8529 | 0.040 |
Why?
|
| Inpatients | 1 | 2010 | 2548 | 0.040 |
Why?
|
| Coronary Vessels | 2 | 2006 | 3096 | 0.040 |
Why?
|
| Homocysteine | 1 | 2021 | 638 | 0.040 |
Why?
|
| Secondary Prevention | 2 | 2020 | 1475 | 0.040 |
Why?
|
| Forecasting | 1 | 2007 | 2928 | 0.040 |
Why?
|
| Time Factors | 7 | 2016 | 39967 | 0.040 |
Why?
|
| Venezuela | 1 | 1997 | 73 | 0.040 |
Why?
|
| Trypanocidal Agents | 1 | 1997 | 41 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2007 | 1418 | 0.040 |
Why?
|
| Dyspnea | 1 | 2004 | 1347 | 0.030 |
Why?
|
| Myocarditis | 1 | 2004 | 788 | 0.030 |
Why?
|
| Heart | 2 | 2012 | 4404 | 0.030 |
Why?
|
| Atrial Fibrillation | 2 | 2009 | 5127 | 0.030 |
Why?
|
| Utilization Review | 1 | 2017 | 382 | 0.030 |
Why?
|
| Catheter Ablation | 1 | 2009 | 2751 | 0.030 |
Why?
|
| Retrospective Studies | 10 | 2016 | 80636 | 0.030 |
Why?
|
| Pericardial Effusion | 1 | 1997 | 247 | 0.030 |
Why?
|
| Trypanosoma cruzi | 1 | 1997 | 206 | 0.030 |
Why?
|
| Logistic Models | 3 | 2017 | 13255 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 11903 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 1997 | 590 | 0.030 |
Why?
|
| Cardiac Tamponade | 2 | 2008 | 175 | 0.030 |
Why?
|
| Survival Rate | 4 | 2013 | 12725 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2007 | 3879 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2015 | 527 | 0.030 |
Why?
|
| United States | 5 | 2017 | 72334 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 2192 | 0.030 |
Why?
|
| Sex Distribution | 2 | 2009 | 2281 | 0.030 |
Why?
|
| Anticoagulants | 3 | 2021 | 4812 | 0.030 |
Why?
|
| Heart Failure | 1 | 2016 | 11669 | 0.020 |
Why?
|
| Rabbits | 1 | 1998 | 4772 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 983 | 0.020 |
Why?
|
| Quality of Life | 2 | 2023 | 13367 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 36426 | 0.020 |
Why?
|
| Age Factors | 3 | 2016 | 18395 | 0.020 |
Why?
|
| Disease Progression | 1 | 2007 | 13506 | 0.020 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 2009 | 42 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 23445 | 0.020 |
Why?
|
| Spain | 1 | 2011 | 487 | 0.020 |
Why?
|
| Adolescent | 4 | 2017 | 88319 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 983 | 0.020 |
Why?
|
| Iliac Vein | 1 | 2009 | 70 | 0.020 |
Why?
|
| Propensity Score | 1 | 2016 | 1913 | 0.020 |
Why?
|
| Phlebography | 1 | 2009 | 326 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 8002 | 0.020 |
Why?
|
| Risk Factors | 5 | 2016 | 74206 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 12463 | 0.020 |
Why?
|
| Young Adult | 4 | 2017 | 59243 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2011 | 5972 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2007 | 318 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2004 | 22176 | 0.020 |
Why?
|
| Angiomyolipoma | 1 | 2007 | 187 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2005 | 473 | 0.010 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2009 | 575 | 0.010 |
Why?
|
| Age Distribution | 1 | 2009 | 2880 | 0.010 |
Why?
|
| History, 21st Century | 1 | 2009 | 1567 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 897 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 694 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2007 | 592 | 0.010 |
Why?
|
| Pulmonary Veins | 1 | 2009 | 743 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 1189 | 0.010 |
Why?
|
| Length of Stay | 1 | 2016 | 6425 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10508 | 0.010 |
Why?
|
| Equipment and Supplies | 1 | 2004 | 273 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2009 | 1121 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 15266 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 14666 | 0.010 |
Why?
|
| Rare Diseases | 1 | 2006 | 622 | 0.010 |
Why?
|
| Foreign-Body Migration | 1 | 2002 | 219 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2007 | 1468 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 2003 | 771 | 0.010 |
Why?
|
| Hypotension | 1 | 2006 | 879 | 0.010 |
Why?
|
| Posture | 1 | 2004 | 957 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 1371 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2009 | 6343 | 0.010 |
Why?
|
| Child | 2 | 1998 | 80153 | 0.010 |
Why?
|
| Chest Pain | 1 | 2006 | 1091 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2011 | 9646 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 5247 | 0.010 |
Why?
|
| Reoperation | 1 | 2009 | 4303 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2006 | 4806 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6484 | 0.010 |
Why?
|
| Boston | 1 | 2010 | 9326 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2012 | 41487 | 0.010 |
Why?
|
| Massachusetts | 1 | 2010 | 8830 | 0.010 |
Why?
|
| Sex Factors | 1 | 2011 | 10552 | 0.010 |
Why?
|
| Radiography | 1 | 2007 | 6965 | 0.010 |
Why?
|
| Animals | 2 | 1998 | 168459 | 0.010 |
Why?
|
| Infant | 1 | 1997 | 36192 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1997 | 42230 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 29874 | 0.010 |
Why?
|
| Oxygen | 1 | 2004 | 4227 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 10209 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 12974 | 0.010 |
Why?
|
| Incidence | 1 | 2009 | 21353 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2007 | 4249 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 9000 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2003 | 5914 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2006 | 12953 | 0.000 |
Why?
|
| Brain | 1 | 2012 | 27112 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 15500 | 0.000 |
Why?
|